10 Roadblocks To Traditional Vendor Selection And How ClinAI Solves Them

By Kalyan Obalampalli (KO), Founder, ClinAI

Vendor selection in clinical trials is a pivotal process. Choosing the right execution partners can shape trial outcomes. Despite this, many sponsors, especially in biotech, rely on outdated, manual methods like Excel to manage critical decisions involving CROs, central labs, and other vendors. Learn about ten widespread inefficiencies in the current approach, including error-prone spreadsheets, lack of standardized templates, poor analytics, and fragmented collaboration.

ClinAI, a next-generation vendor management platform, addresses these pain points by offering automated data capture, customizable RFP templates, built-in analytics, and centralized communication tools. The platform enables real-time vendor comparisons, structured negotiations with version tracking, and audit-ready documentation — significantly reducing selection timelines and enhancing vendor accountability. By treating vendors as true partners rather than transactional suppliers, ClinAI empowers sponsors to make faster, smarter, and more transparent decisions.